Definitive Contract HHSD200201691589C
Award Date
9/1/16
Potential Completion Date
8/31/18
Potential Value
$10M
Federal Agency
CDC Pittsburgh
Awardee
Vysnova Partners, LLC
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Atlanta, GA 30345, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $7,455,151.00 cost-plus-fixed-fee definitive contract to Vysnova Partners, LLC, a for-profit limited liability company, for a Zika Virus Longitudinal Study. The contract has a completion date of September 28, 2022 and does not have a set-aside designation. Vysnova Partners specializes in managing research on infectious diseases and has previously supported federal agencies like the Department of...
This is a $2,999,342 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company. The contract is for enhancing surveillance and cohort studies, and it runs through September 30, 2018. Vysnova Partners has expertise in areas such as clinical trials, data analysis, vector surveillance, and administrative program management. This award is not a set-aside contract. Vysnova Partners holds...
This is a $1,225,604 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for ecological studies. The contract does not have a set-aside designation. Vysnova Partners is a professional services firm that specializes in medical research, clinical trials, disease surveillance, and global health initiatives for federal agencies. Through this contract, the company will provide...
This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023. The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from...
This is a cost-plus-fixed-fee delivery order contract awarded to Vysnova Partners, LLC, a for-profit limited liability company, by the Centers for Disease Control and Prevention (CDC) for professional services in Rwanda. The contract has a ceiling value of $1,355,294.54 and a completion date of April 22, 2025. Vysnova Partners is a prime contractor that specializes in providing professional, scientific, and technical services to federal agencies, with a focus on supporting medical research,...
This is a $3,279,000.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services (HHS), to the University of North Carolina at Chapel Hill (UNC) to conduct research related to the Zika virus and its vector. The contract, which does not have a set-aside designation, was awarded on April 17, 2017, with a completion date of April 16, 2022. UNC, through its Office of Sponsored Research,...
The Centers for Disease Control and Prevention (CDC) awarded a $500,000 firm fixed price contract to The Johns Hopkins University to support Zika diagnostic and vector research efforts. Under the terms of the two-year agreement, set to run from July 2017 through June 2019, the prime contractor will deliver products and services to assist the CDC in addressing the Zika virus. No major subcontractors or set aside designations were indicated. This award advances the CDC's mission to monitor and...
This federal contract award is for STIIRC SUPPORT SERVICES, which refers to the Sexually Transmitted Infections Impact Research Consortium Support Services. The contract was awarded to Vysnova Partners, LLC, a for-profit limited liability company that specializes in providing professional, scientific, and technical services to federal agencies, particularly in the areas of medical research, clinical trials, disease surveillance, and global health initiatives. The contract is a Delivery Order...
This federal contract award was issued by the Defense Health Agency to Vysnova Partners, LLC, a for-profit limited liability company, to provide scientific, technical, and administrative support for infectious disease research and surveillance to identify and characterize medical threats to the warfighter. The contract has a ceiling value of $15,003,075.13 and a performance period through March 12, 2030. It is a cost-plus-fixed-fee delivery order contract, without a set-aside designation....
This is a $495,339.00 cost plus fixed fee delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Vysnova Partners, LLC, a for-profit limited liability company. The contract is for research support services, with performance occurring in Singapore. Vysnova Partners is a firm that specializes in managing research on infectious diseases such as malaria, dengue, Zika, and other acute respiratory/febrile illnesses, and has previously received prime contract...